BeStock  

HCA Healthcare HCA

US equityMarket cap rank #198Medical Care Facilities
$475.57 +$15.24 (+3.31%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $476.00 +0.09%
Open$467.00
Prev close$460.33
Day range$463.50 – $479.77
Volume1.58M
Market cap$99.34B
P/E (TTM)15.8
Dividend yield0.64%

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$19.85B+3.6% YoY
Operating profit$2.94B-0.7% YoY
Net profit$1.85B-2.8% YoY
Diluted EPS$7.27+4.5% YoY
Free cash flow$3.10B-0.8% YoY
Operating cash flow$4.46B

Revenue, last 8 quarters

$18.3BDec '24$18.3BMar '25$18.6BJun '25$19.2BSep '25$19.5BDec '25$19.1BMar '26$20.2BJun '26$19.8BSep '26

Net profit, last 8 quarters

$1.7BDec '24$1.8BMar '25$1.9BJun '25$1.9BSep '25$2.2BDec '25$1.9BMar '26$1.9BJun '26$1.8BSep '26

Diluted EPS by quarter

5.63Dec '246.45Mar '256.83Jun '256.96Sep '258.14Dec '257.15Mar '267.62Jun '267.27Sep '26

Free cash flow by quarter

$1.3BDec '24$660.0MMar '25$3.0BJun '25$3.1BSep '25$870.0MDec '25$895.0MMar '26$1.1BJun '26$3.1BSep '26

Annual revenue

$51.5BFY20$58.8BFY21$60.2BFY22$65.0BFY23$70.6BFY24$75.6BFY25

Profitability & balance sheet

Gross margin42.8%
Operating margin15.3%
Net margin8.6%
Return on assets11.0%
Current ratio0.82
Liabilities / assets107.2%
Cash & investments$908.00M
Total debt$52.43B
Net cash (debt)-$51.52B
Free cash flow / sales7.6%

SEC annual financial snapshot

Standard US-GAAP figures from 10-K filings in USD. Figures may reflect restatements. Checked 2026-11-22 14:51 UTC.

MetricUSDBasisPeriod endFiled / SEC source
Revenue$75.60BAnnual2025-12-312026-02-10
Net income$6.78BAnnual2025-12-312026-02-10
Operating cash flow$12.64BAnnual2025-12-312026-02-10
Total assets$60.72BPeriod end2025-12-312026-02-10
Stockholders’ equity-$6.03BPeriod end2025-12-312026-02-10
Cash and cash equivalents$1.04BPeriod end2025-12-312026-02-10

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $19.85B $20.23B $19.11B $75.60B $19.51B
Total Operating Revenue $19.85B $20.23B $19.11B $75.60B $19.51B
Cost of Revenue $11.40B $11.18B $11.14B $44.23B $11.34B
Gross Profit $8.45B $9.05B $7.97B $31.37B $8.18B
Operating Expense $5.50B $5.99B $5.11B $19.41B $5.00B
Depreciation & Amortization & Depletion $954.00M $944.00M $930.00M $3.52B $911.00M
-Depreciation & Amortization $954.00M $944.00M $930.00M $3.52B $911.00M
Other Operating Expenses $4.55B $5.04B $4.18B $15.89B $4.09B
Operating Profit $2.94B $3.07B $2.86B $11.97B $3.18B
Net Non-Operating Interest Income (Expense) -$607.00M -$599.00M -$584.00M -$2.25B -$572.00M
Non-Operating Interest Expense $607.00M $599.00M $584.00M $2.25B $572.00M
Other Income (Expense) $33.00M $26.00M $8.00M $115.00M $66.00M
Earnings from Equity Interest $20.00M $16.00M $9.00M $78.00M $25.00M
Special Income (Charges) $13.00M $10.00M -$1.00M $37.00M $41.00M
-Gain on Sale Of Business $13.00M $10.00M -$1.00M $37.00M $41.00M
Pretax Profit $2.37B $2.49B $2.29B $9.83B $2.67B
Tax $521.00M $564.00M $430.00M $2.05B $509.00M
Net Profit $1.85B $1.93B $1.86B $7.78B $2.16B
Profit from Continuing Operations $1.85B $1.93B $1.86B $7.78B $2.16B
Minority Interests $270.00M $231.00M $237.00M $998.00M $285.00M
Net Income to Parent Company $1.58B $1.70B $1.62B $6.78B $1.88B
Net Income to Common Stockholders $1.58B $1.70B $1.62B $6.78B $1.88B
Basic EPS $7.36 $7.70 $7.25 $28.70 $8.36
Diluted EPS $7.27 $7.62 $7.15 $28.33 $8.14
Dividend Per Share $0.78 $0.78 $0.78 $2.88 $0.72

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $63.45B $63.25B $61.45B $60.72B $60.72B
Total Current Assets $16.22B $17.19B $16.05B $15.78B $15.78B
Cash and Cash Equivalents & Short-Term Investments $908.00M $1.01B $940.00M $1.04B $1.04B
-Cash and Cash Equivalents $908.00M $1.01B $940.00M $1.04B $1.04B
Receivables $11.51B $12.28B $11.32B $10.87B $10.87B
-Accounts Receivable $11.51B $12.28B $11.32B $10.87B $10.87B
Inventory $1.67B $1.66B $1.68B $1.65B $1.65B
Other Current Assets $2.13B $2.23B $2.11B $2.22B $2.22B
Total Non-Current Assets $47.23B $46.06B $45.40B $44.94B $44.94B
Net PPE $34.48B $33.93B $33.57B $33.27B $33.27B
-Gross PPE $71.84B $70.52B $69.46B $68.41B $68.41B
-Accumulated Depreciation -$37.36B -$36.59B -$35.89B -$35.13B -$35.13B
Investments and Advances $1.28B $1.22B $1.00B $1.12B $1.12B
-Long Term Equity Investment $1.28B $1.22B $1.00B $1.12B $1.12B
Goodwill and Other Intangible Assets $11.20B $10.66B $10.50B $10.29B $10.29B
Other Non-Current Assets $280.00M $258.00M $326.00M $255.00M $255.00M
Total Liabilities $68.05B $66.46B $64.43B $63.49B $63.49B
Total Current Liabilities $19.78B $17.31B $19.26B $16.35B $16.35B
Payables $5.10B $4.75B $4.81B $5.16B $5.16B
-Accounts Payable $5.10B $4.75B $4.81B $4.66B $4.66B
Current Accrued Expenses $6.58B $6.30B $5.92B $4.97B $4.97B
Short-Term Debt and Capital Lease Obligation $8.09B $6.26B $8.53B $5.24B $5.24B
-Current Debt $8.09B $6.26B $8.53B $4.89B $4.89B
Total Non-Current Liabilities $48.27B $49.15B $45.17B $47.14B $47.14B
Long Term Debt and Capital Lease Obligation $44.33B $45.29B $41.31B $43.46B $43.46B
-Long Term Debt $42.40B $43.45B $39.49B $41.60B $41.60B
-Long Term Capital Lease Obligation $1.93B $1.83B $1.82B $1.85B $1.85B
Other Non-Current Liabilities $3.94B $3.86B $3.86B $3.69B $3.69B
Total Equity -$4.60B -$3.21B -$2.98B -$2.77B -$2.77B
Stockholders' Equity -$8.08B -$6.64B -$6.30B -$6.03B -$6.03B
Capital Stock $2.00M $2.00M $2.00M $2.00M $2.00M
-Common Stock $2.00M $2.00M $2.00M $2.00M $2.00M
Retained Earnings -$7.73B -$6.31B -$5.98B -$5.72B -$5.72B
Gains/Losses Not Affecting Retained Earnings -$350.00M -$334.00M -$327.00M -$305.00M -$305.00M
Minority Interests $3.48B $3.43B $3.33B $3.26B $3.26B
-Total Tax Payable – – – $504.00M $504.00M
-Current Capital Lease Obligation – – – $352.00M $352.00M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $4.46B $2.34B $2.01B $12.64B $2.36B
Net cash flow from continuing operations $4.46B $2.34B $2.01B $12.64B $2.36B
Net Income from Continuing Operations $1.85B $1.93B $1.86B $7.78B $2.16B
Gain/Loss from Continuing Operations -$13.00M -$10.00M $1.00M -$37.00M -$41.00M
Depreciation & Depletion & Amortization $954.00M $944.00M $930.00M $3.52B $911.00M
Deferred Tax -$171.00M -$166.00M $435.00M $310.00M -$1.00B
Other Non-Cash Items $50.00M $61.00M $78.00M $239.00M $61.00M
Change in Working Capital $1.66B -$509.00M -$1.37B $418.00M $169.00M
-Change in Receivables $782.00M -$954.00M -$463.00M -$94.00M -$439.00M
-Change in Inventory $108.00M -$106.00M $80.00M -$154.00M -$29.00M
-Change in Payables and Accrued Expense $769.00M $551.00M -$990.00M $666.00M $637.00M
Net cash flow from investing -$1.92B -$1.56B -$1.28B -$4.99B -$1.32B
Net Cash Flow from Continuing Investing Activities -$1.92B -$1.56B -$1.28B -$4.99B -$1.32B
Net PPE Purchase and Sale -$1.36B -$1.23B -$1.12B -$4.94B -$1.49B
Net Business Purchase and Sale -$470.00M -$103.00M -$262.00M -$128.00M $56.00M
Net Investment Purchase and Sale -$94.00M -$223.00M $103.00M $72.00M $98.00M
Net Other Investing Changes $5.00M $0.00 -$4.00M $12.00M $18.00M
Financing Cash Flow -$2.65B -$704.00M -$830.00M -$8.55B -$999.00M
Net Cash Flow from Continuing Financing Activities -$2.65B -$704.00M -$830.00M -$8.55B -$999.00M
Net Issuance Payments Of Debt $723.00M $1.69B $1.38B $3.29B $1.98B
Net Common Stock Issuance -$2.97B -$2.06B -$1.57B -$10.07B -$2.56B
Cash Dividends Paid -$165.00M -$171.00M -$183.00M -$679.00M -$162.00M
Net Other Financing Charges -$237.00M -$157.00M -$453.00M -$1.09B -$261.00M
Ending Cash Balance $908.00M $1.01B $940.00M $1.04B $1.04B
Net Change in Cash -$104.00M $74.00M -$98.00M -$902.00M $43.00M
Beginning Cash Balance $1.01B $940.00M $1.04B $1.93B $997.00M
Effect of Exchange Rate Changes -$1.00M -$1.00M -$2.00M $9.00M $0.00
Free Cash Flow $3.10B $1.10B $895.00M $7.69B $870.00M

Discussion

No comments yet — be the first to weigh in on HCA.

Sign in to join the discussion.

Scroll to Top